Drug Science
Diagnostic Tests
Genetic, molecular, and functional tests that help characterise your cancer, guide treatment decisions, and monitor response — from RGCC and ctDNA to full tumour sequencing.
8
Tests Covered
6
Categories
5
Strong Evidence
RGCC Test (Onconomics / Oncocount)
Circulating tumour cell analysis with personalised chemo & natural agent sensitivity profiling
ctDNA Liquid Biopsy
Detecting cancer DNA fragments in blood — for early detection, monitoring, and resistance profiling
Germline Genetic Testing
Inherited mutation testing for BRCA1/2, Lynch syndrome, and 80+ hereditary cancer genes
Comprehensive Tumour NGS Profiling
Full genomic portrait of a tumour — matches mutations to targeted therapies and trials
Oncotype DX & Prognostic Gene Panels
21-gene or 70-gene expression tests to predict chemo benefit and recurrence risk in early breast cancer
Circulating Tumour Cell (CTC) Count
Counting cancer cells circulating in blood — a real-time window into cancer activity and prognosis
Complete Onco Analysis (Multi-Marker Panel)
A broad blood and tissue panel covering tumour markers, immune function, metabolic status, and inflammation
Immunohistochemistry & Biomarker Staining
Tissue-based protein expression testing — determines cancer subtype and immunotherapy eligibility
These tests should be ordered and interpreted by a qualified oncologist or integrative cancer physician. No test result should change your treatment plan without specialist guidance. Informational only — not medical advice.